SilicoGenesis
SilicoGenesis leverages AI/ML and in-silico pipelines to revolutionize biologics design, discovery, and optimization for pharmaceutical and biotech companies. Their platform, Eve, enables the rapid development of therapeutic lead molecules, significantly reducing the time and cost associated with traditional wet-lab approaches. SilicoGenesis offers services including target characterization, hit identification, lead characterization, and lead optimization, aiming to accelerate the development of novel treatments. They have expanded from South Africa to Belgium and collaborate with major pharmaceutical companies and academic institutions.
SilicoGenesis
SilicoGenesis leverages AI/ML and in-silico pipelines to revolutionize biologics design, discovery, and optimization for pharmaceutical and biotech companies. Their platform, Eve, enables the rapid development of therapeutic lead molecules, significantly reducing the time and cost associated with traditional wet-lab approaches. SilicoGenesis offers services including target characterization, hit identification, lead characterization, and lead optimization, aiming to accelerate the development of novel treatments. They have expanded from South Africa to Belgium and collaborate with major pharmaceutical companies and academic institutions.